These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28526048)

  • 21. Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome.
    Strang J; Marsden J; Cummins M; Farrell M; Finch E; Gossop M; Stewart D; Welch S
    Addiction; 2000 Nov; 95(11):1631-45. PubMed ID: 11219367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report.
    Palis H; MacDonald S; Jun J; Oviedo-Joekes E
    Harm Reduct J; 2021 May; 18(1):57. PubMed ID: 34016137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label study to assess feasibility, safety and cost.
    Rodgers C; Siefried KJ; Ritter A; Belackova V; Treloar C; Jauncey M; Ezard N; Roberts D; Steele M; van den Brink W; Strang J; Oviedo-Joekes E; Lintzeris N; Dunlop AJ; Bell J
    BMJ Open; 2024 Aug; 14(8):e082553. PubMed ID: 39097309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrating injectable opioid agonist treatment into a drug treatment court program: A case study.
    Jun JH; Fairbairn N
    Subst Abus; 2018; 39(4):493-496. PubMed ID: 29949453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Learning from the past, looking to the future - Is there a place for injectable opioid treatment among Australia's responses to opioid misuse?
    Belackova V; Salmon AM; Jauncey M; Bell J
    Int J Drug Policy; 2019 Sep; 71():164-168. PubMed ID: 30975592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting.
    Klimas J; Dong H; Fairbairn N; Socías E; Barrios R; Wood E; Kerr T; Montaner J; Milloy MJ
    Addict Sci Clin Pract; 2018 Feb; 13(1):3. PubMed ID: 29409539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Supervised Injectable Opioid Treatment for the Management of Opioid Dependence.
    Bell J; Belackova V; Lintzeris N
    Drugs; 2018 Sep; 78(13):1339-1352. PubMed ID: 30132259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A chance to stop and breathe: participants' experiences in the North American Opiate Medication Initiative clinical trial.
    Oviedo-Joekes E; Marchand K; Lock K; Chettiar J; Marsh DC; Brissette S; Anis AH; Schechter MT
    Addict Sci Clin Pract; 2014 Sep; 9(1):21. PubMed ID: 25262567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: a case study.
    Oviedo-Joekes E; MacDonald S; Boissonneault C; Harper K
    Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):22. PubMed ID: 33673847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse Events During Treatment Induction With Injectable Diacetylmorphine and Hydromorphone for Opioid Use Disorder.
    Oviedo-Joekes E; Palis H; Guh D; Marsh DC; MacDonald S; Harrison S; Brissette S; Anis AH; Schechter MT
    J Addict Med; 2019; 13(5):354-361. PubMed ID: 30747750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of cocaine contingency management in heroin-assisted treatment: Results of a randomized controlled trial.
    Blanken P; Hendriks VM; Huijsman IA; van Ree JM; van den Brink W
    Drug Alcohol Depend; 2016 Jul; 164():55-63. PubMed ID: 27177805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex work involvement among women with long-term opioid injection drug dependence who enter opioid agonist treatment.
    Marchand K; Oviedo-Joekes E; Guh D; Marsh DC; Brissette S; Schechter MT
    Harm Reduct J; 2012 Jan; 9():8. PubMed ID: 22276954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
    Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
    Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Individual differences in human opioid abuse potential as observed in a human laboratory study.
    Dunn KE; Barrett FS; Brands B; Marsh DC; Bigelow GE
    Drug Alcohol Depend; 2019 Dec; 205():107688. PubMed ID: 31710994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial.
    Strang J; Metrebian N; Lintzeris N; Potts L; Carnwath T; Mayet S; Williams H; Zador D; Evers R; Groshkova T; Charles V; Martin A; Forzisi L
    Lancet; 2010 May; 375(9729):1885-95. PubMed ID: 20511018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study.
    Weiss RD; Potter JS; Griffin ML; Provost SE; Fitzmaurice GM; McDermott KA; Srisarajivakul EN; Dodd DR; Dreifuss JA; McHugh RK; Carroll KM
    Drug Alcohol Depend; 2015 May; 150():112-9. PubMed ID: 25818060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heroin-assisted treatment for opioid dependence: randomised controlled trial.
    Haasen C; Verthein U; Degkwitz P; Berger J; Krausz M; Naber D
    Br J Psychiatry; 2007 Jul; 191():55-62. PubMed ID: 17602126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
    Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expanding access to diacetylmorphine and hydromorphone for people who use opioids in Canada.
    Maghsoudi N; Bowles J; Werb D
    Can J Public Health; 2020 Aug; 111(4):606-609. PubMed ID: 32221867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association between nicotine dependence and physical health among people receiving injectable diacetylmorphine or hydromorphone for the treatment of chronic opioid use disorder.
    Palis H; Marchand K; Karamouzian M; MacDonald S; Harrison S; Guh D; Lock K; Brissette S; Anis AH; Krausz M; Marsh DC; Schechter MT; Oviedo-Joekes E
    Addict Behav Rep; 2018 Jun; 7():82-89. PubMed ID: 29892701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.